CoChat

Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Transferring gut microbiota from one individual to another may enable researchers to "humanize" the gut of animal models and transfer phenotypes between species. To date, most studies of gut microbiota transfer are performed in germ-free mice. In the studies presented, it was tested whether an antibiotic treatment approach could be used instead. C57BL/6 mice were treated with ampicillin prior to inoculation at weaning or eight weeks of age with gut microbiota from lean or obese donors. The gut microbiota and clinical parameters of the recipients was characterized one and six weeks after inoculation. The results demonstrate, that the donor gut microbiota was introduced, established, and changed the gut microbiota of the recipients. Six weeks after inoculation, the differences persisted, however alteration of the gut microbiota occurred with time within the groups. The clinical parameters of the donor phenotype were partly transmissible from obese to lean mice, in particularly β cell hyperactivity in the obese recipients. Thus, a successful inoculation of gut microbiota was not age dependent in order for the microbes to colonize, and transferring different microbial compositions to conventional antibiotic-treated mice was possible at least for a time period during which the microbiota may permanently modulate important host functions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep05922

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Gut microbiota analysis by denaturing gradient gel electrophoresis (DGGE). (a) Feces samples were collected from ampicillin-treated B6 recipient mice just before inoculation. The picture shows a segment of a gel illustrating DGGE profiles of three weeks old ampicillin-treated mice before they were randomized to receive microbiota inoculation from donor mice. Each lane represents the gut microbiota profile of one mouse. (b) Principal Component Analysis (PCA) plot of DGGE profiles from feces samples collected from recipient mice one week after inoculation at three weeks of age with either C57BL/6 (green balls n = 12; donor: light green ball n = 1) or B6.-Lepob (orange balls n = 13; donor: pink ball n = 1) microbiota. (c) PCA plot of DGGE profiles from feces samples collected from recipient mice six weeks after inoculation at three weeks of age with either C57BL/6 (green balls n = 12; donor: light green ball n = 1) or B6.-Lepob orange balls n = 13; donor: pink ball n = 1) microbiota. (d) PCA plot of DGGE profiles from feces samples collected from recipient mice one week after inoculation at eight weeks of age with either BALB/c (dark blue balls n = 14; donor: light blue ball n = 1), B6.-Lepob (orange balls n = 15; donor: pink ball n = 1) microbiota, or PBS (yellow balls n = 14). (e) PCA plot of DGGE profiles from feces samples collected from recipient mice six weeks after inoculation at eight weeks of age with either BALB/c (dark blue balls n = 14; donor: light blue ball n = 1), B6.-Lepob (orange balls n = 13; donor: pink ball n = 1) microbiota, or PBS (yellow balls n = 15). (f–h) Scatterplots of PC1 (x-component), PC2 (y-component), and PC3 (z-component) respectively from DGGE profiles of feces samples shown in D. (i–k) Scatterplots of PC1 (x-component), PC2 (y-component), and PC3 (z-component) respectively from DGGE profiles of feces samples shown in E. (l) The picture shows a segment of a gel illustrating DGGE profiles of mice one week after inoculation with BALB/c microbiota (blue), B6.-Lepob microbiota (orange), or PBS (yellow). The red circles mark examples of differences in appearance of bands between the two inoculated groups. (m) The picture shows a segment of a gel illustrating DGGE profiles of mice six weeks after inoculation with BALB/c microbiota (blue), B6.-Lepob microbiota (orange), or PBS (yellow).
Figure 1 Gut microbiota analysis by denaturing gradient gel electrophoresis (DGGE). (a) Feces samples were collected from ampicillin-treated B6 recipient mice just before inoculation. The picture shows a segment of a gel illustrating DGGE profiles of three weeks old ampicillin-treated mice before they were randomized to receive microbiota inoculation from donor mice. Each lane represents the gut microbiota profile of one mouse. (b) Principal Component Analysis (PCA) plot of DGGE profiles from feces samples collected from recipient mice one week after inoculation at three weeks of age with either C57BL/6 (green balls n = 12; donor: light green ball n = 1) or B6.-Lepob (orange balls n = 13; donor: pink ball n = 1) microbiota. (c) PCA plot of DGGE profiles from feces samples collected from recipient mice six weeks after inoculation at three weeks of age with either C57BL/6 (green balls n = 12; donor: light green ball n = 1) or B6.-Lepob orange balls n = 13; donor: pink ball n = 1) microbiota. (d) PCA plot of DGGE profiles from feces samples collected from recipient mice one week after inoculation at eight weeks of age with either BALB/c (dark blue balls n = 14; donor: light blue ball n = 1), B6.-Lepob (orange balls n = 15; donor: pink ball n = 1) microbiota, or PBS (yellow balls n = 14). (e) PCA plot of DGGE profiles from feces samples collected from recipient mice six weeks after inoculation at eight weeks of age with either BALB/c (dark blue balls n = 14; donor: light blue ball n = 1), B6.-Lepob (orange balls n = 13; donor: pink ball n = 1) microbiota, or PBS (yellow balls n = 15). (f–h) Scatterplots of PC1 (x-component), PC2 (y-component), and PC3 (z-component) respectively from DGGE profiles of feces samples shown in D. (i–k) Scatterplots of PC1 (x-component), PC2 (y-component), and PC3 (z-component) respectively from DGGE profiles of feces samples shown in E. (l) The picture shows a segment of a gel illustrating DGGE profiles of mice one week after inoculation with BALB/c microbiota (blue), B6.-Lepob microbiota (orange), or PBS (yellow). The red circles mark examples of differences in appearance of bands between the two inoculated groups. (m) The picture shows a segment of a gel illustrating DGGE profiles of mice six weeks after inoculation with BALB/c microbiota (blue), B6.-Lepob microbiota (orange), or PBS (yellow).CC BY-NC-ND · PubMed Central
Figure 2 Quantitative gut microbiota comparison of taxa derived from analysis with GUt Low-Density Array (GULDA). (a–l) Relative abundance of selected 16S rRNA gene targets with given microbial primers. Cecum samples from C57BL/6 (n = 1) and B6.-Lepob (n = 1) donor mice and fecal samples from recipient mice one week and six weeks after inoculation at three weeks of age with either C57BL/6 (white bars, n = 10) or B6.-Lepob microbiota (black bars, n = 13) are shown. (m) Ratio (fold-change) of selected 16S rRNA gene targets in feces from recipient mice at one week to six weeks after inoculation at three weeks of age with C57BL/6 microbiota (n = 4). Different shading of columns represent the four phyla Firmicutes (white), Bacteroidetes (light grey), Proteobacteria (grey), Verrucomicrobia (black). P < 0.1 for a hypothetical value different from 0 (no change) is indicated. (n) Ratio (fold-change) of selected 16S rRNA gene targets in feces from recipient mice at one week to six weeks after inoculation at three weeks of age with B6.-Lepob microbiota (n = 5). All samples analyzed were quantified in duplicate. The relative abundance values are derived by normalizing with a universal bacterial primer-target. The bar charts show means ± SEM. * represents P < 0.05.
Figure 2 Quantitative gut microbiota comparison of taxa derived from analysis with GUt Low-Density Array (GULDA). (a–l) Relative abundance of selected 16S rRNA gene targets with given microbial primers. Cecum samples from C57BL/6 (n = 1) and B6.-Lepob (n = 1) donor mice and fecal samples from recipient mice one week and six weeks after inoculation at three weeks of age with either C57BL/6 (white bars, n = 10) or B6.-Lepob microbiota (black bars, n = 13) are shown. (m) Ratio (fold-change) of selected 16S rRNA gene targets in feces from recipient mice at one week to six weeks after inoculation at three weeks of age with C57BL/6 microbiota (n = 4). Different shading of columns represent the four phyla Firmicutes (white), Bacteroidetes (light grey), Proteobacteria (grey), Verrucomicrobia (black). P < 0.1 for a hypothetical value different from 0 (no change) is indicated. (n) Ratio (fold-change) of selected 16S rRNA gene targets in feces from recipient mice at one week to six weeks after inoculation at three weeks of age with B6.-Lepob microbiota (n = 5). All samples analyzed were quantified in duplicate. The relative abundance values are derived by normalizing with a universal bacterial primer-target. The bar charts show means ± SEM. * represents P < 0.05.CC BY-NC-ND · PubMed Central
Figure 3 Microbiota transfer at weaning changes metabolic parameters in antibiotic-treated recipient mice. (a) Weekly body weight (gram) of recipient mice after inoculation with either C57BL/6 (males n = 3; females n = 7) or B6.-Lepob microbiota (males n = 4; females n = 8) at three weeks of age. (b) Area under the curve (AUC) calculated from weight data in A. (c) AUC of weekly food consumption (gram) per mouse in average per cage in six weeks from inoculation in recipient mice inoculated with either C57BL/6 (males n = 2; females n = 4) or B6.-Lepob microbiota (males n = 4; females n = 3) at three weeks of age. (d) Weight (gram) of body fat pads (the sum of inguinal fat pads, retroperitoneal pad pads, epididymal fat pads or uterine fat pads in males and females respectively) in recipient mice six weeks after inoculation with either C57BL/6 (males n = 3; females n = 9) or B6.-Lepob microbiota (males n = 4; females n = 8) at three weeks of age. (e) HbA1c (glycated haemoglobin, %) concentration in the blood of recipient mice six weeks after inoculation with either C57BL/6 (n = 9, green bars) or B6.-Lepob (n = 11, orange bars) microbiota at three weeks of age. (f–h) Oral glucose tolerance test (OGTT) one, four, and six weeks (respectively) after inoculation with either C57BL/6 (n = 12) or B6.-Lepob (n = 12) microbiota at three weeks of age. Tail blood glucose relative to baseline value (−15 min) is shown at given time points after oral gavage of glucose. * represents P < 0.05 difference in peak values. (i) Fasting blood insulin levels relative to insulin levels at inoculation at three weeks of age. Insulin levels are shown four and six weeks post inoculation (PI). * represents P < 0.05. Mean ± SEM.
Figure 3 Microbiota transfer at weaning changes metabolic parameters in antibiotic-treated recipient mice. (a) Weekly body weight (gram) of recipient mice after inoculation with either C57BL/6 (males n = 3; females n = 7) or B6.-Lepob microbiota (males n = 4; females n = 8) at three weeks of age. (b) Area under the curve (AUC) calculated from weight data in A. (c) AUC of weekly food consumption (gram) per mouse in average per cage in six weeks from inoculation in recipient mice inoculated with either C57BL/6 (males n = 2; females n = 4) or B6.-Lepob microbiota (males n = 4; females n = 3) at three weeks of age. (d) Weight (gram) of body fat pads (the sum of inguinal fat pads, retroperitoneal pad pads, epididymal fat pads or uterine fat pads in males and females respectively) in recipient mice six weeks after inoculation with either C57BL/6 (males n = 3; females n = 9) or B6.-Lepob microbiota (males n = 4; females n = 8) at three weeks of age. (e) HbA1c (glycated haemoglobin, %) concentration in the blood of recipient mice six weeks after inoculation with either C57BL/6 (n = 9, green bars) or B6.-Lepob (n = 11, orange bars) microbiota at three weeks of age. (f–h) Oral glucose tolerance test (OGTT) one, four, and six weeks (respectively) after inoculation with either C57BL/6 (n = 12) or B6.-Lepob (n = 12) microbiota at three weeks of age. Tail blood glucose relative to baseline value (−15 min) is shown at given time points after oral gavage of glucose. * represents P < 0.05 difference in peak values. (i) Fasting blood insulin levels relative to insulin levels at inoculation at three weeks of age. Insulin levels are shown four and six weeks post inoculation (PI). * represents P < 0.05. Mean ± SEM.CC BY-NC-ND · PubMed Central
Figure 4 Microbiota transfer to adult antibiotic-treated mice changes their metabolic parameters. (a) Weekly body weight (gram) of recipient mice after inoculation with either BALB/c (female n = 8, male n = 8) or B6.-Lepob (female n = 8, male n = 8) at eight weeks of age. (b) Area under the curve calculated from weight data in A. (c) AUC of weekly food consumption (gram) per cage in six weeks from inoculation in recipient mice inoculated with either BALB/c (males n = 2; females n = 2) or B6.-Lepob microbiota (males n = 2; females n = 2) at eight weeks of age. (d) HbA1c (glycated haemoglobin, %) concentration in the blood of recipient mice six weeks after inoculation with either BALB/c (n = 16) or B6.-Lepob (n = 16) at eight weeks of age. (e) Oral glucose tolerance test (OGTT) six weeks after inoculation with either BALB/c (n = 16) or B6.-Lepob (n = 16) at eight weeks of age. Tail blood glucose relative to baseline value (−15 min) is shown at given time points after oral gavage of glucose. Mean ± SEM is shown. * represents P < 0.05; ** represent P < 0.01.
Figure 4 Microbiota transfer to adult antibiotic-treated mice changes their metabolic parameters. (a) Weekly body weight (gram) of recipient mice after inoculation with either BALB/c (female n = 8, male n = 8) or B6.-Lepob (female n = 8, male n = 8) at eight weeks of age. (b) Area under the curve calculated from weight data in A. (c) AUC of weekly food consumption (gram) per cage in six weeks from inoculation in recipient mice inoculated with either BALB/c (males n = 2; females n = 2) or B6.-Lepob microbiota (males n = 2; females n = 2) at eight weeks of age. (d) HbA1c (glycated haemoglobin, %) concentration in the blood of recipient mice six weeks after inoculation with either BALB/c (n = 16) or B6.-Lepob (n = 16) at eight weeks of age. (e) Oral glucose tolerance test (OGTT) six weeks after inoculation with either BALB/c (n = 16) or B6.-Lepob (n = 16) at eight weeks of age. Tail blood glucose relative to baseline value (−15 min) is shown at given time points after oral gavage of glucose. Mean ± SEM is shown. * represents P < 0.05; ** represent P < 0.01.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 179

Metadata

Authors
Ellekilde, M., Selfjord, E., Larsen, C. S., Jakesevic, M., Rune, I., Tranberg, B., Vogensen, F. K., Nielsen, D. S., Bahl, M. I., Licht, T. R., Hansen, A. K., & Hansen, C. H. F.
Affiliations
  • University of Copenhagen (DK)
  • Technical University of Denmark (DK)
Corresponding author
Ellekilde, Merete
Venue
Scientific Reports
Published
2014-08-01
Volume
4
Issue
1
Pages
5922-5922
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2144079797
Cited by
153
References
31
Citations by year
2026: 4 · 2025: 9 · 2024: 9 · 2023: 8 · 2022: 18 · 2021: 21 · 2020: 14 · 2019: 16 · 2018: 19 · 2017: 17 · 2016: 10 · 2015: 7 · 2014: 1
FWCI
4.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
Funders
Strategiske Forskningsråd
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
antibiotic-treated mice, obesity, lean mice, ampicillin, microbiota colonization, C57BL/6 mice
MeSH terms
Ampicillin, Animals, Anti-Bacterial Agents, Female, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Obese, Gastrointestinal Tract, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.